Triple
T6733862
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Doha Declaration on the TRIPS Agreement and Public Health |
E153703
|
entity |
| Predicate | influenced |
P9
|
FINISHED |
| Object |
2005 TRIPS amendment on public health (Article 31bis)
The 2005 TRIPS amendment on public health (Article 31bis) is a World Trade Organization rule change that allows countries to export patented medicines made under compulsory licenses to nations lacking sufficient pharmaceutical manufacturing capacity, in order to improve access to essential drugs.
|
E616453
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: 2005 TRIPS amendment on public health (Article 31bis) | Statement: [Doha Declaration on the TRIPS Agreement and Public Health, influenced, 2005 TRIPS amendment on public health (Article 31bis)]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: 2005 TRIPS amendment on public health (Article 31bis) Context triple: [Doha Declaration on the TRIPS Agreement and Public Health, influenced, 2005 TRIPS amendment on public health (Article 31bis)]
-
A.
Doha Declaration on the TRIPS Agreement and Public Health
The Doha Declaration on the TRIPS Agreement and Public Health is a 2001 WTO ministerial statement affirming that intellectual property rules should not prevent members from protecting public health and ensuring access to affordable medicines.
-
B.
World Health Organization Model List of Essential Medicines
The World Health Organization Model List of Essential Medicines is a periodically updated catalog of the most effective, safe, and cost-efficient medicines deemed essential for meeting the priority health needs of populations worldwide.
-
C.
Agreement on Trade-Related Aspects of Intellectual Property Rights
The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) is a key international treaty that sets minimum global standards for the protection and enforcement of intellectual property rights among World Trade Organization members.
-
D.
GATT 1994 Article XXI
GATT 1994 Article XXI is the World Trade Organization provision that allows members to take trade-restrictive measures they consider necessary for the protection of their essential security interests.
-
E.
Drug Price Competition and Patent Term Restoration Act of 1984
The Drug Price Competition and Patent Term Restoration Act of 1984, commonly known as the Hatch-Waxman Act, is a U.S. law that streamlined the approval of generic drugs while providing patent term extensions to brand-name drug manufacturers to balance innovation and competition.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: 2005 TRIPS amendment on public health (Article 31bis) Triple: [Doha Declaration on the TRIPS Agreement and Public Health, influenced, 2005 TRIPS amendment on public health (Article 31bis)]
Generated description
The 2005 TRIPS amendment on public health (Article 31bis) is a World Trade Organization rule change that allows countries to export patented medicines made under compulsory licenses to nations lacking sufficient pharmaceutical manufacturing capacity, in order to improve access to essential drugs.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: 2005 TRIPS amendment on public health (Article 31bis) Target entity description: The 2005 TRIPS amendment on public health (Article 31bis) is a World Trade Organization rule change that allows countries to export patented medicines made under compulsory licenses to nations lacking sufficient pharmaceutical manufacturing capacity, in order to improve access to essential drugs.
-
A.
Doha Declaration on the TRIPS Agreement and Public Health
The Doha Declaration on the TRIPS Agreement and Public Health is a 2001 WTO ministerial statement affirming that intellectual property rules should not prevent members from protecting public health and ensuring access to affordable medicines.
-
B.
World Health Organization Model List of Essential Medicines
The World Health Organization Model List of Essential Medicines is a periodically updated catalog of the most effective, safe, and cost-efficient medicines deemed essential for meeting the priority health needs of populations worldwide.
-
C.
Agreement on Trade-Related Aspects of Intellectual Property Rights
The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) is a key international treaty that sets minimum global standards for the protection and enforcement of intellectual property rights among World Trade Organization members.
-
D.
GATT 1994 Article XXI
GATT 1994 Article XXI is the World Trade Organization provision that allows members to take trade-restrictive measures they consider necessary for the protection of their essential security interests.
-
E.
Drug Price Competition and Patent Term Restoration Act of 1984
The Drug Price Competition and Patent Term Restoration Act of 1984, commonly known as the Hatch-Waxman Act, is a U.S. law that streamlined the approval of generic drugs while providing patent term extensions to brand-name drug manufacturers to balance innovation and competition.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c6880bdd68819097de8b6099992682 |
completed | March 27, 2026, 1:37 p.m. |
| NER | Named-entity recognition | batch_69c6d16d51dc8190869167d86e8f081f |
completed | March 27, 2026, 6:50 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69c70b0502d081909662028e2b40c7f3 |
completed | March 27, 2026, 10:56 p.m. |
| NEDg | Description generation | batch_69c70ba06a5c81909b65b52d21d37104 |
completed | March 27, 2026, 10:58 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69c70c755054819087d0db6f94d69eae |
completed | March 27, 2026, 11:02 p.m. |
Created at: March 27, 2026, 2:09 p.m.